Redwood Pharma attending OIS-ASRS Conference in San Francisco
Redwood Pharma AB (publ) announces that it will be attending the Ophthalmology Innovation Summit-American Society for Retina Specialists (OIS-ASRS) in San Francisco, California, USA on August 8, 2016. The summit will focus on innovative treatments for back of the eye or retinal diseases. One of the more important diseases of the retina include Age-Related Macular Degeneration (AMD).
The Ophthalmology Innovation Summit was created to facilitate meaningful interactions and business partnerships between physicians, entrepreneurs, investors and industry executives who are driving ophthalmic innovation. OIS addresses key issues, both hurdles and opportunities, while showcasing the most promising private ophthalmic companies.
”Redwood Pharma will be attending one of the leading innovation summits in the area of eye care. The Company will be open for partnering discussions for the development of new therapeutics using the IntelliGel® slow-release drug delivery platform,” says CEO Martin Vidaeus.
For more information:
Martin Vidaeus, CEO Redwood Pharma AB (publ)
Tel: +46 (0) 70 232 29 29